More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...

The Trump administration's mass firings at the U.S. Food and Drug Administration have removed employees critical to reviewing ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Kennedy’s leadership is already making the biggest US measles outbreak since 2019 worse. The number of cases across five ...

The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.

Cantor Fitzgerald analysts renewed their criticism of U.S. Health Secretary Robert F. Kennedy Jr. on Thursday, saying the ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.

The health secretary’s indiscriminate layoffs will undermine his own priorities.

President Donald Trump’s allies and adversaries are deeply divided over how to improve the U.S. health care system.